BERLIN (Reuters) – Swiss pharmaceutical group Novartis is winding up the German biotech company Morphosys, which it acquired at the beginning of the year, German news outlet WirtschaftsWoche reported on Thursday, saying 330 jobs would be affected.
“In November 2024, we made the decision to close the Morphosys sites in Germany and the U.S. by the end of 2025 and to integrate all portfolio activities into Novartis,” WiWo cited Novartis as saying.
Novartis did not immediately respond to an emailed request for comment from Reuters.
($1 = 0.9610 euros)
(Writing by Friederike Heine; Editing by Madeline Chambers)
Some 330 jobs hit as Novartis closes Morphosys, WiWo reports Canadian News Today.
Hence then, the article about some 330 jobs hit as novartis closes morphosys wiwo reports was published today ( ) and is available on canadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Some 330 jobs hit as Novartis closes Morphosys, WiWo reports )
Also on site :
- Oddity Tech Ltd. Group Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ODD
- 1974 No. 1 Hit Became a Career-Defining Classic
- Jennifer Aniston Shares Surprising Reaction To Ex-Husband Justin Theroux's Baby Announcement